Global leadership Antibiotice is the world leader in manufacturing the active pharmaceutical ingredient Nystatin and has sustained recognition by USP as an international quality reference since 2017, signaling strong product credibility and potential for strategic partnerships in high-margin API supply and contract manufacturing.

Financing momentum Recent multi-million euro funding and significant loan facilities from Banca Transilvania indicate strong financial backing for strategic projects, presenting an opening for joint ventures, long-term supply agreements, and co-development of critical drug manufacturing capabilities.

R&D expansion Investment in an new R&D center focused on critical medicines suggests opportunities to collaborate on formulation development, clinical pipeline support, and early access programs for hospitals and national health systems.

Cost-effective access As a main Romanian producer of affordable antiinfective generics delivered to hospitals, Antibiotice offers opportunities to engage health systems and distributors seeking cost-saving procurement, price-competitive tenders, and API-grade supply continuity.

Quality and compliance ISO/EU GMP, European Pharmacopoeia compliance, and FDA authorization position Antibiotice as a trusted partner for regulated markets, enabling expansions into new regions requiring stringent quality standards and reliable supply assurances.